Evidence map›Paper›PMID 18679377›Full record

ArticleLaboratory investigation; a journal of technical methods and pathology2008

Placental expression of ceruloplasmin in pregnancies complicated by severe preeclampsia.

Seth Guller, Catalin S Buhimschi, Yula Y Ma, Se Te J Huang, Liubin Yang, Edward Kuczynski, Eduardo Zambrano, Charles J Lockwood, Irina A Buhimschi

Open access · bronzeAbstract read
In one paragraph

Article in Laboratory investigation; a journal of technical methods and pathology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Observational
  4. Review
  5. Article
  6. Review
  7. Iron and Pregnancy.Advances in experimental medicine and biology · 2025
    Review
  8. Article
  9. Review
  10. Article
  11. Iron Metabolism and Ferroptosis in Physiological and Pathological Pregnancy.International journal of molecular sciences · 2022
    Review
  12. Molecular Functions of Ceruloplasmin in Metabolic Disease Pathology.Diabetes, metabolic syndrome and obesity : targets and therapy · 2022
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Iron homeostasis during pregnancy.The American journal of clinical nutrition · 2017
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Seth GullerDepartment of Obstetrics/Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT 06520-8063, USA. seth.guller@yale.edu
Catalin S Buhimschi
Yula Y Ma
Se Te J Huang
Liubin Yang
Edward Kuczynski
Eduardo Zambrano
Charles J Lockwood
Irina A Buhimschi
Yale University · US

Funding

Targeting Placental Pathophysiology in IUGR and PreeclampsiaR01HD033909 · NICHD · YALE UNIVERSITY · PI GULLER, SETH M. · 2002 to 2010
$2.5M
Targeting Placental Pathophysiology in IUGR and PreeclampsiaR56HD033909 · NICHD · YALE UNIVERSITY · PI GULLER, SETH M. · 2008 to 2008
$317k
GLUCOCORTICOIDS AND MATRIX PROTEINS AT PARTURITIONR29HD033909 · NICHD · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI GULLER, SETH · 1995 to 1999
–
NICHD NIH HHS HD33909NICHD NIH HHS R01 HD033909NICHD NIH HHS R29 HD033909NICHD NIH HHS R56 HD033909
6 · The paper itself

Abstract

There is consensus that ischemia/reperfusion injury associated with preeclampsia (PE) promotes both placental damage and the release of factors leading to maternal endothelium dysfunction, a hallmark of this potentially life-threatening syndrome. These factors include plasminogen activator inhibitor-1 (PAI-1) and soluble fms-like tyrosine kinase-1 (sFlt-1). The goal of this study was to further characterize placental factors involved in the pathophysiology of PE. Thus, DNA microarray gene profiling was utilized to identify mRNA differentially regulated in placentas from women with severe PE compared to both preterm (PC) and term control (TC) groups. Microarray studies detected an upregulation of mRNA for ceruloplasmin, a copper-containing iron transport protein with antioxidant ferroxidase properties, in PE compared to PC and TC placentas, respectively. Quantitative real-time PCR confirmed these results by demonstrating significant increases in ceruloplasmin mRNA in PE vs PC and TC placentas. Supporting previous reports, the expression of sFlt-1 and PAI-1 were also upregulated in PE placentas. Immunohistochemistry localized ceruloplasmin to the intervillous space in PE and PC placentas, whereas stronger syncytial staining was noted in PE. Western blotting confirmed a significant increase in ceruloplasmin levels in placental tissue in PE compared to PC groups. PCR identified the presence of mRNA for ceruloplasmin in primary cultures of syncytiotrophoblasts, but not villous-derived fibroblasts, suggesting that syncytium is the site of ceruloplasmin synthesis in placenta. Hypoxic treatment (1% O(2)) of syncytiotrophoblasts enhanced levels of ceruloplasmin mRNA approximately 25-fold, a significantly greater upregulation than that noted for PAI-1 and sFlt-1, suggesting that enhanced ceruloplasmin expression is a sensitive marker of syncytial hypoxia. We suggest that syncytial ceruloplasmin and its associated ferroxidase activity, induced by the hypoxia accompanying severe PE, is important in an endogenous cellular program to mitigate the damaging effects of subsequent reperfusion injury at this site.

Indexed as

AdultCase-Control StudiesCells, CulturedCeruloplasminFemaleGene Expression ProfilingHumansHypoxiaOligonucleotide Array Sequence AnalysisPlacentaPre-EclampsiaPregnancyPremature BirthRNA, MessengerTrophoblastsUp-RegulationCeruloplasminRNA, Messenger

Identifiers

PMID18679377
PMCPMC2682720
OpenAlexW2099198156

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.